Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

Kinnate Biopharma

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
2018
11-50
San Diego, California, United States
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Personalized Medicine Technologies

Investment Funding

Last Funding Stage

Series C

Total Funding Amount

195.M

Last Funding Amount

98.M

Last Funding Date

26-08-2020

Startup Stage

M&A

Lead Investors

RA Capital Management, OrbiMed, Fidelity, Vida Ventures, Janus Henderson Investors

Revenue

Less than $1M

People

Founders

Something missing or incorrect on this page? Help us enrich this information